Access cutting-edge glioblastoma treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access glioblastoma specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related glioblastoma treatment provided free
This is to study if neoadjuvant atezolizumab therapy is beneficial for patients with recurrent glioblastoma and a low mutational burden.
Sponsor: Duke University
Check if you qualify for this glioblastoma clinical trial in San Francisco, CA
If you're searching for glioblastoma treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glioblastoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.